- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04409821
Tele-based Psychological Emotional Support for Informal CARegivers of COVID-19 Patients in Intensive Care (CO-CarES)
November 15, 2023 updated by: Annika von Heymann, Rigshospitalet, Denmark
COVID-19 Caregiver Emotional Support
The experience of a loved one's stay in a COVID-19 intensive care unit (ICU), either intubated or on respiratory support, forces family caregivers (hereafter 'caregivers') to face core existential fears, such as uncertainty and death.
It also poses a serious threat to basic human needs for autonomy, competence, and relatedness, as family caregivers have no control over the illness, and limited prior competence in dealing with critical illness.
COVID-19 likely aggravates this experience, as social distancing cuts caregivers off from visiting patients in the ICU, from using their usual social supportive network and the threat of infection extends to caregivers themselves, their children and family.
Combined, these extreme circumstances put caregivers in emotional turmoil and in need of psychological support and assistance in managing difficult emotions.
ICU caregivers are at risk of developing clinically relevant symptoms of anxiety or posttraumatic stress.
During the patient's ICU stay, caregivers experience peri-traumatic distress, such as helplessness, grief, frustration and anger, that may predict later posttraumatic stress disorder (PTSD).
Symptoms of anxiety and PTSD may last for months to years after the patient's discharge.
Further, caregivers of patients who die in an ICU may be at greater risk of prolonged grief disorder.
Supportive interventions may reduce psychological late effects in ICU caregivers, but the primary focus of the majority of interventions has been on communication or surrogate decision making.
The CO-CarES study aims to develop and test the feasibility of a tele-delivered psychological intervention to enable caregivers of ICU patients with COVID-19 to better endure the overwhelming uncertainty and emotional strain and reduce the risk of posttraumatic stress and prolonged grief.
The study hypothesizes that providing psychological intervention during and after the patients' hospitalization, can decrease peri-traumatic distress during ICU hospitalization and decrease risk of post-traumatic stress, anxiety, depression and perceived stress following discharge, as well as prolonged grief in bereavement.
A secondary hypothesis is that changes in emotion regulation mediate effects of the intervention on long-term psychological outcomes.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aarhus, Denmark
- Skejby Hospital
-
Copenhagen, Denmark, 2100
- Rigshospitalet
-
Horsens, Denmark
- Hospitalsenheden Vest, Horsens
-
Hvidovre, Denmark
- Hvidovre Hospital
-
Kolding, Denmark
- Sygehus Lillebælt, Kolding
-
Odense, Denmark
- Odense University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- close relatives or friends of a patient hospitalized in an intensive care or intermediary care wards with COVID-19
- capable of completing online questionnaires
- speak Danish sufficiently for a therapeutic dialogue
- provide informed consent
Exclusion Criteria:
- suffering from a severe psychiatric disorder (such as schizophrenia) or in ongoing psychotherapeutic treatment for a psychiatric disorder (such as major depression generalized anxiety disorder or others), that cannot be paused
- unable to complete verbal phone- or videoconferencing calls
- unable to complete electronic questionnaires
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Tele-delivered psychological intervention
Weekly tele-delivered psychological intervention
|
The intervention consists of two (or one, if preferred by caregivers) weekly tele-sessions during the ICU stay, lasting up to 30 minutes, and two sessions in the month after discharge from or death in the ICU.
Sessions will be conducted via phone-calls or video-conferencing.
Therapists will 1) validate caregivers' subjective experience, 2) normalize and psychoeducate about emotional reactions, and 3) offer emotion regulation drawing on contemporary cognitive treatment packages of decentering, acceptance and emotion tolerance.
Sessions for bereaved caregivers will include psycho-education about grief, assessment of risk for adverse outcomes and information about available support, if needed.
The intervention will be performed based on an intervention manual.
The content of the intervention will be continually adapted and tailored to the needs of the participating caregivers by involving all caregivers in co-creating the intervention trough brief post-session interviews.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recruitment rate
Time Frame: At inclusion
|
Rate of consent among informed eligible participants
|
At inclusion
|
Completion rate
Time Frame: During and post-intervention (1 month)
|
Rates of completion of intervention sessions among participants
|
During and post-intervention (1 month)
|
Peri-traumatic distress inventory (negative emotions)
Time Frame: Pre-post intervention (1 month after discharge/death)
|
Symptoms of peri-traumatic distress, min.
score 0, max score 24, higher score corresponds to worse distress
|
Pre-post intervention (1 month after discharge/death)
|
Impact of Events Scale (6 item)
Time Frame: 1 month post intervention
|
Posttraumatic stress, min.
score 6, max score 24, higher score corresponds to worse distress
|
1 month post intervention
|
Impact of Events Scale (6 item)
Time Frame: 6 months post intervention
|
Posttraumatic stress, min.
score 6, max score 24, higher score corresponds to worse distress
|
6 months post intervention
|
Impact of Events Scale (6 item)
Time Frame: 12/13 months post intervention
|
Posttraumatic stress, min.
score 6, max score 24, higher score corresponds to worse distress
|
12/13 months post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prolonged Grief-13-scale
Time Frame: 6 and 13 months
|
Prolonged Grief, scored according to diagnostic criteria for prolonged grief disorder
|
6 and 13 months
|
PROMIS Depression (8 item scale)
Time Frame: Baseline to 1, 6, and 12/13 months
|
Symptoms of depression, min.
score 8, max score 40, higher score corresponds to worse symptoms
|
Baseline to 1, 6, and 12/13 months
|
PROMIS Anxiety (8 item scale)
Time Frame: Baseline to 1, 6, and 12/13 months
|
Symptoms of anxiety, min.
score 8, max score 40, higher score corresponds to worse symptoms
|
Baseline to 1, 6, and 12/13 months
|
Perceived Stress Scale (4 item)
Time Frame: Baseline to 1, 6, and 12/13 months
|
Perceived stress, min.
score 0, max score 16, higher score corresponds to worse stress
|
Baseline to 1, 6, and 12/13 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Short Penn State Worry Questionnaire (3 items)
Time Frame: Baseline to 1, 6, and 12/13 months
|
Worry, min.
score 3, max score 15, higher score corresponds to greater worry
|
Baseline to 1, 6, and 12/13 months
|
Brooding subscale of Ruminative Responses Scale
Time Frame: Baseline to 1, 6, and 12/13 months
|
Brooding, min.
score 5, max score 20, higher score corresponds to greater brooding/rumination
|
Baseline to 1, 6, and 12/13 months
|
Intolerance of uncertainty Scale (2 item)
Time Frame: Baseline to 1, 6, and 12/13 months
|
Intolerance of uncertainty, min score 2, max score 8, greater score indicates greater uncertainty intolerance
|
Baseline to 1, 6, and 12/13 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Annika von Heymann, PhD, Department of Oncology, Rigshospitalet, Denmark
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 29, 2020
Primary Completion (Actual)
May 31, 2022
Study Completion (Actual)
May 31, 2022
Study Registration Dates
First Submitted
May 22, 2020
First Submitted That Met QC Criteria
May 28, 2020
First Posted (Actual)
June 1, 2020
Study Record Updates
Last Update Posted (Estimated)
November 16, 2023
Last Update Submitted That Met QC Criteria
November 15, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Coronavirus Infections
- Coronaviridae Infections
- Nidovirales Infections
- RNA Virus Infections
- Virus Diseases
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Pneumonia, Viral
- Pneumonia
- Lung Diseases
- Trauma and Stressor Related Disorders
- Stress Disorders, Traumatic
- COVID-19
- Stress Disorders, Post-Traumatic
Other Study ID Numbers
- P-2020-544
- 0216-00030B (Other Grant/Funding Number: Independent Research Fund Denmark)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID
-
European Institute of OncologyFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; Azienda Ospedaliera... and other collaboratorsCompleted
-
Owlstone LtdCambridge University Hospitals NHS Foundation TrustCompleted
-
Erasmus Medical CenterDa Vinci Clinic; HGC RijswijkNot yet recruitingPost-COVID-19 Syndrome | Long COVID | Long Covid19 | Post COVID-19 Condition | Post-COVID Syndrome | Post COVID-19 Condition, Unspecified | Post-COVID ConditionNetherlands
-
Sultan Qaboos UniversityCompletedCOVID-19 | Non-CovidOman
-
Assiut UniversityRecruiting
-
Jilin UniversityUnknown
-
Indonesia UniversityRecruitingPost-COVID-19 Syndrome | Long COVID | Post COVID-19 Condition | Post-COVID Syndrome | Long COVID-19Indonesia
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention SrlCompletedPost Acute Sequelae of COVID-19 | Post COVID-19 Condition | Long-COVID | Chronic COVID-19 SyndromeItaly
-
Miami VA Healthcare SystemNot yet recruiting
Clinical Trials on Tele-delivered psychological intervention
-
University of AarhusAarhus University HospitalRecruiting
-
Universiti Sains MalaysiaNot yet recruiting
-
Samsung Medical CenterRecruitingChronic Obstructive Pulmonary DiseaseKorea, Republic of
-
Rhode Island HospitalUniversity of Mississippi Medical CenterRecruiting
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingBlood Pressure | Psychological StressUnited States
-
Guangxi Medical UniversityCompletedBurnout | PsychologicalChina
-
Alexandria UniversityCompletedPsychological Distress | ResilienceEgypt
-
Mayo ClinicRecruitingDepression | PTSD | Anxiety | Psychological Trauma | Post Intensive Care Unit SyndromeUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Obesity
-
Wayne State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetesUnited States